Multiprofile Hospital For Active Treatment St. Panteleimon Yambol AD

The trials here

What the 8 trials at this site are about, from their registry records.

Conditions

• Chronic spontaneous urticaria2 trials
• Heart failure2 trials
• Atrial fibrillation1 trial
• Chronic kidney disease1 trial
• High blood pressure1 trial
• Obesity1 trial
• Type 2 diabetes1 trial
• Vitiligo1 trial

Phase

• Phase 38 trials

Status

• Recruiting4 trials
• Active, not recruiting3 trials
• Completed1 trial

Lead sponsor

• Boehringer Ingelheim4 trials
• Celldex Therapeutics1 trial
• Celldex Therapeutics Inc.1 trial
• Janssen Research & Development, LLC1 trial
• Pfizer1 trial

Running trials

• Recruiting

  Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria

  2025-522878-36-00· Phase 3· Celldex Therapeutics Inc.· Source

• Recruiting

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

  NCT06935370· Phase 3· Boehringer Ingelheim· Source

• Active, not recruiting

  A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

  NCT06445023· Phase 3· Celldex Therapeutics· Source

• Recruiting

  A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

  NCT06424288· Phase 3· Boehringer Ingelheim· Source

• Active, not recruiting

  A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2

  NCT06072183· Phase 3· Pfizer· Source

• Active, not recruiting

  A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation

  NCT05757869· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure2 recruiting
• Chronic spontaneous urticaria1 recruiting
• High blood pressure1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)

  NCT06077864· Phase 3· Boehringer Ingelheim· Source